Coenzyme Q 10 Softgel
Natural health product licensed in Canada
- Licence holder
- Shenyang Yangshengzhiyou Biological Technology Co. Ltd
- NPN or DIN-HM
- 80058749
- Status
- Active licence
- Licence date
- 5 March 2015
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine E: up to 60 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 30 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 100 milligramme | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Microorganismes CoQ10 - Cellule entière pour biosynthèse | 100 milligramme | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 1,750 milligramme Potency : 24 % Flavonoid glycosides | 35 milligramme | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 6 % Terpene lactones | Not specified | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 18 % Eicosapentaenoic acid | 405 milligramme | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 18 % Eicosapentaenoic acid | 405 milligramme | Not calculated |
| Huile de poisson Source : Salmonidae - en entier Potency : 18 % Eicosapentaenoic acid | 405 milligramme | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 18 % Eicosapentaenoic acid | 405 milligramme | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 12 % Docosahexaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 12 % Docosahexaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Salmonidae - en entier Potency : 12 % Docosahexaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 12 % Docosahexaenoic acid | Not specified | Not calculated |
| Vitamine E Source : Glycine max - Graine | 30 milligramme | 60,000 µg |
| Vitamine E Source : d-alpha tocophérol | 30 milligramme | 60,000 µg |
Non-medicinal ingredients
Eau purifiée, Lécithine, Gélatine, Dioxyde de titane, Glycérine, Cire d'abeille jaune
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps to maintain and/or support cardiovascular health. An antioxidant for the maintenance of good health. Source of omega-3 fatty acids for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. A factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Keep out of reach of children. Store in a cool dry place and avoid excessive heat. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking medications for diabetes, blood pressure, or seizures. Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care practitioner if migraine frequency increases, and associated nausea and vomiting persist or worsen.
- Contre-indications
Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding.
Source
Official Health Canada record, licence 80058749
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.